Xing-Jie Liang got the Ph.D. degree at the National Key Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China. He finished his postdoc with Dr. Michael M. Gottesman at the Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA. Then, he worked as a Research Fellow at the Surgical Neurology Branch, National Institute of Neurological Diseases and Strokes (NINDS) for 2 years. He was an Assistant Professor at the Department of Radiology, School of Medicine, Howard University, before he moved back to China as a Deputy Director of the Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences. Dr. Liang is a Principal Investigator at the Division of Nanomedicine and Nanobiology, National Center for Nanoscience and Technology of China. His research interests are in the elucidating mechanisms to improve nanomedicinal bioavailability by nanotechnology in vivo and novel strategies to increase therapeutic effect on cancers and AIDS. Developing drug delivery strategies for prevention/treatment of AIDS and cancers is the current program ongoing in Dr. Liang’s lab based on the understanding of basic physiochemical and biological processes of nanomedicine. Most protocols are employed for delivering therapeutic molecules (chemical compounds or nucleic acids) to actively target cells or tissues in vivo to enhance drug safety and efficacy.
Biography Updated on 7 November 2012